CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate

L Stolarova, P Kleiblova, M Janatova, J Soukupova… - Cells, 2020 - mdpi.com
Germline alterations in many genes coding for proteins regulating DNA repair and DNA
damage response (DDR) to DNA double-strand breaks (DDSB) have been recognized as …

DNA damage kinase signaling: checkpoint and repair at 30 years

MC Lanz, D Dibitetto, MB Smolka - The EMBO journal, 2019 - embopress.org
From bacteria to mammalian cells, damaged DNA is sensed and targeted by DNA repair
pathways. In eukaryotes, kinases play a central role in coordinating the DNA damage …

CHK2 kinase in the DNA damage response and beyond

L Zannini, D Delia, G Buscemi - Journal of molecular cell …, 2014 - academic.oup.com
The serine/threonine kinase CHK2 is a key component of the DNA damage response. In
human cells, following genotoxic stress, CHK2 is activated and phosphorylates> 20 proteins …

Checkpoint responses to DNA double-strand breaks

DP Waterman, JE Haber… - Annual review of …, 2020 - annualreviews.org
Cells confront DNA damage in every cell cycle. Among the most deleterious types of DNA
damage are DNA double-strand breaks (DSBs), which can cause cell lethality if unrepaired …

Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2

HC Reinhardt, MB Yaffe - Current opinion in cell biology, 2009 - Elsevier
In response to DNA damage eukaryotic cells activate cell cycle checkpoints—complex
kinase signaling networks that prevent further progression through the cell cycle. Parallel to …

Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response

HC Reinhardt, MB Yaffe - Nature reviews Molecular cell biology, 2013 - nature.com
Coordinated progression through the cell cycle is a complex challenge for eukaryotic cells.
Following genotoxic stress, diverse molecular signals must be integrated to establish …

Conflicting interpretation of genetic variants and cancer risk by commercial laboratories as assessed by the prospective registry of multiplex testing

J Balmaña, L Digiovanni, P Gaddam… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Massively parallel sequencing allows simultaneous testing of multiple genes
associated with cancer susceptibility. Guidelines are available for variant classification; …

Targeting the checkpoint to kill cancer cells

J Benada, L Macurek - Biomolecules, 2015 - mdpi.com
Cancer treatments such as radiotherapy and most of the chemotherapies act by damaging
DNA of cancer cells. Upon DNA damage, cells stop proliferation at cell cycle checkpoints …

Repair of topoisomerase I‐mediated DNA damage

Y Pommier, JM Barcelo, VA Rao, O Sordet… - Progress in nucleic acid …, 2006 - Elsevier
Publisher Summary This chapter discusses the use of inhibitors of tyrosyl-DNA
phosphodiesterase (Tdp1) and Chk1/2 in combination with Topoisomerase I (TopI) …

CHK2 kinase: cancer susceptibility and cancer therapy–two sides of the same coin?

L Antoni, N Sodha, I Collins, MD Garrett - Nature Reviews Cancer, 2007 - nature.com
In the past decade, CHK2 has emerged as an important multifunctional player in the DNA-
damage response signalling pathway. Parallel studies of the human CHEK2 gene have also …